Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease.
Chaiwong W, Takheaw N, Pata S, Laopajon W, Duangjit P, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Chuensirikulchai K, Cheyasawan P, Liwsrisakun C, Kasinrerk W. Chaiwong W, et al. Among authors: takheaw n. Vaccine. 2023 Sep 15;41(40):5901-5909. doi: 10.1016/j.vaccine.2023.08.034. Epub 2023 Aug 18. Vaccine. 2023. PMID: 37599143
Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals.
Takheaw N, Liwsrisakun C, Laopajon W, Pata S, Chaiwong W, Inchai J, Duangjit P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Kasinrerk W. Takheaw N, et al. Heliyon. 2023 Apr;9(4):e15653. doi: 10.1016/j.heliyon.2023.e15653. Epub 2023 Apr 20. Heliyon. 2023. PMID: 37095993 Free PMC article.
Humoral and cellular immune responses against SARS-CoV-2 variants of concern induced by heterologous CoronaVac/ChAdOx-1 versus homologous ChAdOx-1 vaccination in the elderly.
Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Duangjit P, Inchai J, Chuensirikulchai K, Cheyasawan P, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Kasinrerk W. Liwsrisakun C, et al. Among authors: takheaw n. Asian Pac J Allergy Immunol. 2023 Feb 11. doi: 10.12932/AP-120822-1434. Online ahead of print. Asian Pac J Allergy Immunol. 2023. PMID: 36773278 Free article.
Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study.
Chaiwong W, Takheaw N, Laopajon W, Pata S, Duangjit P, Inchai J, Pothirat C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A, Tajarernmuang P, Niyatiwatchanchai N, Trongtrakul K, Chuensirikulchai K, Cheyasawan P, Liwsrisakun C, Kasinrerk W. Chaiwong W, et al. Among authors: takheaw n. Vaccines (Basel). 2022 Dec 18;10(12):2176. doi: 10.3390/vaccines10122176. Vaccines (Basel). 2022. PMID: 36560586 Free PMC article.
23 results